openPR Logo
Press release

New Report Examines the Growth of Obesity Treating Neuromodulation System Market Forecast to 2025

Obesity is a condition with the excess body fat and it is usually defined by 20% or more weight than the idea weight. Obesity is a health risk and obstruct person from performing day-to-day activities. Excess weight contributes to the various diseases including, high blood pressure, stroke, diabetes, heath attack, osteoarthritis and others. The WHO has defines obesity of a bod mass index of 30. According to the WHO, obesity is considered as fifth leading risk of death. It has become a major public health problem all over the world and is a result of combination of various causes such as, genetic and behaviors of individuals. Neuromodulation has shown some benefit in treatment of obesity and it is less invasive than the gastric banding and gastric bypass, which are surgical treatment option for obesity. Obesity treating neuromodulation system works by manipulation the appetite signal between gut and the brain.

Request for TOC @ https://www.persistencemarketresearch.com/toc/19147

Obesity Treating Neuromodulation System Market: Drivers and Restraint

The global obesity treating neuromodulation systems market is primarily driven by the increasing prevalence of obese population. According to WHO, at least 2.8 million people die each year due to the obesity. Increasing adoption of novel technology and advancement in the neuromodulation devices is also expected to drive the growth in the obesity treating neuromodulation system market. Increasing awareness among people regarding benefit of neuromodulation system over tradition treatment and increasing approval are also expected to fuel the growth of the market. Complications associated with the neuromodulation devices and hesitation among people to get implant for obesity treatment is expected to be restraint in the growth of obesity treating neuromodulation systems market.

Obesity Treating Neuromodulation System Market: Segmentation

The global obesity treating neuromodulation system market can be segmented on the basis of product type, end user and region.

On the basis of product type the global obesity treating neuromodulation system market can be segmented into:

Vagus Nerve Stimulator
Splanchnic Nerve Stimulator
Deep Brain Stimulator
Spinal Cord Stimulator
Autonomous Nerve Stimulator
Other

On the basis of end user the global obesity treating neuromodulation system market can be segmented into:

Hospitals
Ambulatory Surgical Centers
Clinics

Obesity Treating Neuromodulation System Market: Overview

The global obesity treating neuromodulation system market is expected to show a significant growth over the forest period. Over the last few years, number of population with the obesity has grown significantly and increasing demand for less invasive treatment is expected to drive the growth of obesity treating neuromodulation system market. Increasing approval of neuromodulation systems by the regulatory bodies and increasing adoption of these new technology by the patient is expected to drive the growth of the market. Vagus nerve stimulators market segment is expected to be biggest and fastest growing segment of obesity treating neuromodulation system market. As, it interfere with the hunger signal from the gut to the brain and reduce the craving for food. Other neurostimulation systems are also expected to show a significant growth in the obesity treating neuromodulation system market.

Obesity Treating Neuromodulation System Market: Region Wise Outlook

The global obesity treating neuromodulation system market can be segmented into regions: North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North America region dominates the global obesity treating neuromodulation system market and is expected to continue to dominate the market over the forecast period. High adoption of neuromodulation system and increased regulatory approval of these devices in the region is expected to be factor for the growth of obesity treating neuromodulation system market. Europe is the second biggest market for the obesity treating neuromodulation system. Increasing prevalence of obesity and presence of market players is also driving the market of obesity treating neuromodulation system market in North America and Europe.

Make an Enquiry @ https://www.persistencemarketresearch.com/samples/19147

Obesity Treating Neuromodulation System Market: Key Players

Some of the market players in the global obesity treating neuromodulation system market are, Medtronic plc., Cyberonics, Inc., St. Jude Medical, Inc., BioControl Medical, Leptos Medical, Inc., EnteroMedics, Inc., Nevro Corp., and Nuvectra.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
T: +1-646-568-7751
Tollfree: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web: www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New Report Examines the Growth of Obesity Treating Neuromodulation System Market Forecast to 2025 here

News-ID: 800822 • Views:

More Releases from Persistence Market Research

Antimicrobial Textile Chemicals Market to Surpass US$ 19.3 Bn by 2032 Fueled by Rising Hygiene and Functional Fabric Demand
Antimicrobial Textile Chemicals Market to Surpass US$ 19.3 Bn by 2032 Fueled by …
According to the latest study by Persistence Market Research, the global antimicrobial textile chemicals market is projected to grow from US$ 12.0 Bn in 2025 to US$ 19.3 Bn by 2032, registering a CAGR of 7.0% during the forecast period. Growing awareness of hygiene, increasing demand for functional and medical textiles, and innovations in performance fabrics are major forces reshaping the industry landscape. ➤Overview of the Market The antimicrobial textile chemicals market
Automotive Remote Diagnostics Market to Reach USD 42.1 Billion by 2031, Growing at a CAGR of 16.6% | Persistence Market Research
Automotive Remote Diagnostics Market to Reach USD 42.1 Billion by 2031, Growing …
The global Automotive Remote Diagnostics Market is experiencing strong momentum, backed by rapid digitization in the automotive sector, the rise of connected vehicles, and the need for real-time vehicle monitoring. According to Persistence Market Research, the market is projected to grow from USD 14.4 billion in 2024 to USD 42.1 billion by 2031, reflecting a robust CAGR of 16.6% during the forecast period. Remote diagnostics has become a key enabler
Adventure Tourism Market to Reach $1,773.6 Bn by 2032 at 16.1% CAGR Driven by Thrill-Seeking Travel Trends
Adventure Tourism Market to Reach $1,773.6 Bn by 2032 at 16.1% CAGR Driven by Th …
Overview of the Market The global adventure tourism market is experiencing rapid transformation as travelers increasingly seek unique, experiential, and adrenaline-fueled activities over traditional leisure tourism. Estimated at US$ 623.7 billion in 2025, the market is projected to surge to US$ 1,773.6 billion by 2032, reflecting an extraordinary CAGR of 16.1%. This exponential growth can be attributed to the rising demand for authentic travel experiences, growing awareness of outdoor recreational opportunities,
Hexagonal Boron Nitride Market Surpass US$ 1.38 Bn by 2032 with 5.1% CAGR - Persistence Market Research
Hexagonal Boron Nitride Market Surpass US$ 1.38 Bn by 2032 with 5.1% CAGR - Pers …
➤Overview of the Market The global hexagonal boron nitride (h-BN) market is steadily growing as industries demand materials that deliver exceptional thermal stability, lubricity, and electrical insulation. Often referred to as "white graphite," h-BN combines a layered crystalline structure with remarkable chemical inertness, making it indispensable across high-temperature, electrical, and lubrication applications. Industries such as aerospace, automotive, electronics, and metallurgy leverage h-BN for its ability to withstand extreme environments while maintaining

All 5 Releases


More Releases for Obesity

Anti-Obesity Drugs Market Grows Rapidly, Driven by Obesity Rates and Therapeutic …
Anti-Obesity Drugs Market valued at USD 5.9 Bn in 2024, growing at 16.5% CAGR to reach USD 20.02 Bn by 2032. Driven by GLP-1 therapies and rising obesity rates. Anti Obesity Drugs Market Overview: The anti-obesity drugs market is undergoing significant transformation as awareness about obesity-related health risks rises globally. With growing concern over lifestyle-related disorders, there is an increasing emphasis on medical intervention as a complement to traditional weight management strategies.
03-18-2025 | Health & Medicine
Getnews
Fuzzle joins The Obesity Society & The Obesity Action Coalition; Promotes Habit- …
Building healthy, sustainable habits for long-term weight management success. Tampa, FL - March 18, 2025 - Fuzzle, an emerging leader in the wellness landscape, is pleased to announce that it's now a Member of The Obesity Society, as well as the Obesity Action Coalition, marking a new milestone in the company's mission to transform how individuals approach weight loss. Image: https://www.globalnewslines.com/uploads/2025/03/77da787ae98a633847c70fc22e2943c7.jpg Fuzzle supports individuals in their wellness journey through non-invasive, drug-free strategies. With
Pediatric Obesity Management Market - Healthy Habits for Life: Advancing Pediatr …
Newark, New Castle, USA: The "Pediatric Obesity Management Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Pediatric Obesity Management Market: https://www.growthplusreports.com/report/pediatric-obesity-management-market/8930 This latest report researches the industry structure,
Anti-Obesity Drugs Market - From Obesity to Vitality: Leading the Way in Effecti …
Newark, New Castle, USA - new report, titled Anti-Obesity Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Anti-Obesity Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Anti-Obesity Drugs market. The report offers an overview of the market, which
Increasing Prevalence of Obesity Driving Obesity/Bariatric Surgery Devices Marke …
The global obesity/bariatric surgery devices market revenue stood at $1.4 billion in 2016, and it is expected to rise to $2.8 billion by 2023. Furthermore, the market will progress at a CAGR of 9.9% from 2017 to 2023 (forecast period), as per the estimates of the market research company, P&S Intelligence. The major growth drivers of the market are the rising incidence of obesity, owing to unhealthy diets and lifestyle
Fast Food and Obesity
Most of the fast food in the market contains a large quantity of sugar, #carbs and fats with a lesser quantity of vitamins and minerals. The unhealthy food ingredients in the fast food are further increased with increased portion size. The person will still consume the whole meal regardless of being completely full. People cannot stop ravishing on fast food because it is available for low cost and in close